Study of NMB (Company's Name) Drug Ejecting Balloon for Arteriovenous Fistulae

The Use of NMB Drug Ejecting Balloon for Arteriovenous (AV) Dialysis Fistulae

The purpose of this study is to demonstrate the safety and effectiveness of the use of NMB's percutaneous transluminal angioplasty (PTA) Balloon.

Inclusion Criteria:

• patients 18 years and older
• Patients with arteriovenous fistula with obstructive lesion
• Patient who is willing and able to sign a written informed consent

Exclusion Criteria:

• age < 18
• female with child bearing potential
• Previous participation in another study with any investigational drug or device within the past 30 days
• Life expectancy of less than 12 months